Exact Mass: 300.1127
Exact Mass Matches: 300.1127
Found 195 metabolites which its exact mass value is equals to given mass value 300.1127,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Salidroside
Salidroside is a glycoside. Salidroside is a natural product found in Plantago australis, Plantago coronopus, and other organisms with data available. See also: Sedum roseum root (part of); Rhodiola crenulata root (part of). Salidroside is a prolyl endopeptidase inhibitor. Salidroside alleviates cachexia symptoms in mouse models of cancer cachexia via activating mTOR signalling. Salidroside protects dopaminergic neurons by enhancing PINK1/Parkin-mediated mitophagy. Salidroside is a prolyl endopeptidase inhibitor. Salidroside alleviates cachexia symptoms in mouse models of cancer cachexia via activating mTOR signalling. Salidroside protects dopaminergic neurons by enhancing PINK1/Parkin-mediated mitophagy.
Desmedipham
CONFIDENCE standard compound; INTERNAL_ID 3738
5-Nitro-2-(3-phenylpropylamino)benzoic acid
D006133 - Growth Substances > D043924 - Angiogenesis Modulating Agents D000970 - Antineoplastic Agents > D020533 - Angiogenesis Inhibitors D006133 - Growth Substances > D006131 - Growth Inhibitors
Phenmedipham
CONFIDENCE standard compound; INTERNAL_ID 3779 D010575 - Pesticides > D006540 - Herbicides D016573 - Agrochemicals
2-(3-Hydroxyphenyl)ethanol 1'-glucoside
2-(3-Hydroxyphenyl)ethanol 1-glucoside is found in fruits. 2-(3-Hydroxyphenyl)ethanol 1-glucoside is a constituent of Sambucus nigra (elderberry). Constituent of Sambucus nigra (elderberry). 2-(3-Hydroxyphenyl)ethanol 1-glucoside is found in fruits.
4-Methoxybenzyl glucoside
4-Methoxybenzyl glucoside is found in fruits. 4-Methoxybenzyl glucoside is present in fennel and marrow (flowers). Present in fennel and marrow (flowers). 4-Methoxybenzyl glucoside is found in herbs and spices and fruits.
1-{2-[(3-Ethylphenyl)amino]-2-oxoethyl}-6-oxo-1,6-dihydropyridine-3-carboxylic acid
Etifoxine
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics Etifoxine, a non-benzodiazepine GABAergic compound, is a positive allosteric modulator of α1β2γ2 and α1β3γ2 subunit-containing GABAA receptors. Etifoxine reveals anxiolytic and anticonvulsant properties in rodents[1][2][3].
Salidroside
Salidroside is a member of the class of compounds known as O-glycosyl compounds. O-glycosyl compounds are glycoside in which a sugar group is bonded through one carbon to another group via a O-glycosidic bond. Salidroside is soluble (in water) and a very weakly acidic compound (based on its pKa). Salidroside can be found in olive, which makes salidroside a potential biomarker for the consumption of this food product. Salidroside (Rhodioloside) is a glucoside of tyrosol found in the plant Rhodiola rosea. It is thought to be one of the compounds responsible for the antidepressant and anxiolytic actions of this plant, along with rosavin. Salidroside may be more active than rosavin, even though many commercially marketed Rhodiola rosea extracts are standardised for rosavin content rather than salidroside . Salidroside is a prolyl endopeptidase inhibitor. Salidroside alleviates cachexia symptoms in mouse models of cancer cachexia via activating mTOR signalling. Salidroside protects dopaminergic neurons by enhancing PINK1/Parkin-mediated mitophagy. Salidroside is a prolyl endopeptidase inhibitor. Salidroside alleviates cachexia symptoms in mouse models of cancer cachexia via activating mTOR signalling. Salidroside protects dopaminergic neurons by enhancing PINK1/Parkin-mediated mitophagy.
3-Butyl-1-(hydroxymethyl)-1-(4-methylphenyl)sulfonylurea
(3Z,6E)-1-Bromo-2-hydroxy-3,7,11-trimethyldodeca-3,6,10-triene
[1R-(1alpha,4alpha,4aalpha,8abeta)]-4-Bromo-1,2,3,4,4a,5,8,8a-octahydro-1,4a-dimethyl-7-(1-methylethyl)-1-naphthalenol
Isobrasudol
Phenmedipham
D010575 - Pesticides > D006540 - Herbicides D016573 - Agrochemicals CONFIDENCE standard compound; EAWAG_UCHEM_ID 94
Etifoxine
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics Etifoxine, a non-benzodiazepine GABAergic compound, is a positive allosteric modulator of α1β2γ2 and α1β3γ2 subunit-containing GABAA receptors. Etifoxine reveals anxiolytic and anticonvulsant properties in rodents[1][2][3].
7-[(4-methoxyphenyl)methyl]-1,3-dimethylpurine-2,6-dione
(3alpha, 4beta, 5beta)-form-3-Bromo-11-eudesmen-5-ol
(2beta, 4beta, 5beta)-form-2-Bromo-11-eudesmen-5-ol
1-<(3S*,3aR*,4R*,7S*,7aS*)-7-bromo-7a-methyl-3-(1-methylethyl)octahydro-1H-inden-4-yl>ethanone|1-[(3S*,3aR*,4R*,7S*,7aS*)-7-bromo-7a-methyl-3-(1-methylethyl)octahydro-1H-inden-4-yl]ethanone|7-Acetyl-4-bromo-1-isopropyl-3alpha-methylindane
6-{5-[(5E)-oct-5-en-7-ynyl]thiophen-2-yl}hex-5-ynoic acid
1beta-bromo-cycloopposita-4beta-ol|5-bromo-1-isopropyl-2,5a-dimethyl-decahydro-cyclopropa[a]inden-2-ol|5a,7a(H)-1beta-bromo-6,8-cycloeudesma-4beta-ol|6,8-cycloeudesmane
(1R)-1-O-(beta-D-glucopyranosyl)-1-phenylethylene glycol|2-O-beta-glucosyl-(1R)-phenylethylene glycol|crenulatanoside C
(R)-(-)-pyridindolol K2|(R)-(?)-pyridindolol K2|16-O-acetylpyridindolol
1-(beta-Carbolin-1-yl)-3,4,5-trihydroxy-1-pentanone
Icariside D2
Icariside D2 is a glycoside. Icariside D2 is a natural product found in Schisandra propinqua, Cyclopia subternata, and other organisms with data available.
DESMEDIPHAM
CONFIDENCE standard compound; EAWAG_UCHEM_ID 144
Xylure
relative retention time with respect to 9-anthracene Carboxylic Acid is 0.716 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.718 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.712 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.713
8phiC8SPC (STANDARD)
Auto-extracted from 131001_neg_02.mzML; CONFIDENCE Reference Standard (Level 1); Kindly provided by Jennifer Field, Oregon State University; Synthesis according to P.W. Taylor and G. Nickless, J. Chromotography, 178 (1979) 259-269.
SPA-8C (SAMPLE)
Auto-extracted from 131001_neg_03.mzML; CONFIDENCE Tentative identification: isomers possible (Level 3)
C14H20O7_4-(2-Hydroxyethyl)phenyl beta-D-glucopyranoside
(2S,3R,4S,5S,6R)-2-[4-(2-hydroxyethyl)phenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
(2S,3R,4S,5S,6R)-2-[4-(2-hydroxyethyl)phenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol_major
2-(3-Hydroxyphenyl)ethanol 1'-glucoside
5-bromo-1-isopropyl-2,5a-dimethyl-decahydro-cyclopropa[a]inden-2-ol
4-[(2-methoxy-4-nitrophenyl)azo]-N,N-dimethyl-Benzenamine
2,4-Pentadien-2-ol,5-(phenylamino)-1-(phenylimino)-, hydrochloride (1:1)
(2S)-4-Oxo-2-(3-thiazolidinylcarbonyl)-1-pyrrolidinecarboxylic acid tert-butyl ester
2,2,2-TRIFLUORO-1-(3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)ETHANONE
1H-PYRROLO[2,3-B]PYRIDIN-4-OL, 2-(3,4,5-TRIMETHOXYPHENYL)-
1-PHENYLAMINO-5-PHENYLIMINO-1,3-PENTADIEN-2-OL HYDROCHLORIDE
Butanoic acid,4-chloro-, 2-(diphenylmethylene)hydrazide
8-N-BOC-AMINO-1,5-DIHYDRO-[1,2]DIAZEPINO[4,5,6-CD]INDOL-6-ONE
2-amino-1-(4-aminophenyl)pyrrolo[3,2-b]quinoxaline-3-carbonitrile
2-[[2-methyl-4-[(4-nitrophenyl)azo]phenyl]amino]ethanol
2-ethoxy-2-[(2-nitrophenyl)amino]-1-phenyl-ethanone
(alphaR)-alpha-Hydroxy-N-[2-(4-nitrophenyl)ethyl]benzeneacetamide
N-(7-γ-glutamyl)-α-naphthylamide,N-(γ-L-GLUTAMYL)-1-NAPHTHYLAMIDE
4,4,5,5-TETRAMETHYL-2-(4-TRIFLUOROVINYLOXY-PHENYL)-[1,3,2]DIOXABOROLANE
Benzaldehyde,4-hydroxy-3-methoxy-, 2-[(4-hydroxy-3-methoxyphenyl)methylene]hydrazone
2-(CHLOROMETHYL)-2-METHYL-3-(4-METHYLPHENYL)-1,2,3,4-TETRAHYDROQUINAZOLIN-4-ONE
(R)-tert-butyl 4-oxo-2-(thiazolidine-3-carbonyl)pyrrolidine-1-carboxylate
2-(4-BUTYLPHENYL)-6-CHLORO-2H-1,2,3-BENZOTRIAZOL-5-AMINE
((Carbonylbis(azanediyl))bis(3,1-phenylene))diboronic acid
3-[(4-fluorophenyl)methyl]-7,7-dimethyl-6,8-dihydrochromene-2,5-dione
(3-CHLORO-PHENYL)-(4-PIPERAZIN-1-YL-PHENYL)-METHANONE
N-(2-(3,4-Dichlorophenyl)ethyl)-N-methyl-2-(1-pyrrolidinyl)ethylamine
Diethyl (4-hydroxy-2-oxo-4-phenylbutyl)phosphonate
rhodosin
Salidroside is a prolyl endopeptidase inhibitor. Salidroside alleviates cachexia symptoms in mouse models of cancer cachexia via activating mTOR signalling. Salidroside protects dopaminergic neurons by enhancing PINK1/Parkin-mediated mitophagy. Salidroside is a prolyl endopeptidase inhibitor. Salidroside alleviates cachexia symptoms in mouse models of cancer cachexia via activating mTOR signalling. Salidroside protects dopaminergic neurons by enhancing PINK1/Parkin-mediated mitophagy.
4-[1-Methyl-5-(methoxycarbonyl)pentyl]benzenesulfonic acid
1-[4-Hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-trimethylsilylpyrimidine-2,4-dione
4-amino-5-[2-amino-3-(1H-imidazol-5-yl)propanoyl]peroxy-5-oxopentanoic acid
4,7-Dihydroxy-N,N,N-trimethyl-4,10-dioxo-3,5,9-trioxa-4lambda~5~-phosphaundecan-1-aminium
[5-(4-Nitrophenyl)-2-furanyl]-(1-piperidinyl)methanone
4-[[(4-Methoxyanilino)-oxomethyl]amino]benzoic acid methyl ester
3-(2,3-dihydro-1,4-benzodioxin-3-yl)-N-(3-hydroxy-2-pyridinyl)propanamide
6-Amino-3-tert-butyl-4-thiophen-2-yl-2,4-dihydroisoxazolo[5,4-b]pyridine-5-carbonitrile
2-[[2-(3-Methoxyphenoxy)-1-oxoethyl]amino]benzamide
2-(3,4-Diethoxyphenyl)-5-(2-furanyl)-1,3,4-oxadiazole
1-Prop-2-enyl-5-[1-(3-pyridinylmethylamino)ethylidene]-1,3-diazinane-2,4,6-trione
2-[[(2R)-3-acetyloxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
6,6-Dimethyl-9-thiophen-2-yl-5,7,8a,9-tetrahydro-[1,2,4]triazolo[5,1-b]quinazolin-8-one
2-[[(2R)-2-acetyloxy-3-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
NPPB
D006133 - Growth Substances > D043924 - Angiogenesis Modulating Agents D000970 - Antineoplastic Agents > D020533 - Angiogenesis Inhibitors D006133 - Growth Substances > D006131 - Growth Inhibitors
2-(hydroxymethyl)-6-[2-(4-hydroxyphenyl)ethoxy]oxane-3,4,5-triol
Nexinhib20
Nexinhib20 is a specific Rab27a-JFC1 interaction inhibitor with a calculated IC50 of 2.6 μM. Nexinhib20 significantly inhibits superoxide anion production. Nexinhib20 efficiently decreases exocytosis of azurophilic granules in neutrophils stimulated with fMLP, GM-CSF or both. Nexinhib20 has a significant anti-inflammatory activity[1].
3-bromo-2a,4a,5,8-tetramethyl-octahydrocyclobuta[d]inden-7-ol
methyl 2-({5-[(r)-hydroxy(phenyl)methyl]pyridin-2-yl}formamido)acetate
methyl 2-({5-[hydroxy(phenyl)methyl]pyridin-2-yl}formamido)acetate
5-bromo-1,1,2a,5a-tetramethyl-octahydrocyclopropa[f]azulen-2-ol
(3s,3as,4r,7s,7as)-7-bromo-4,7a-dimethyl-3-(2-methylprop-1-en-1-yl)-hexahydro-1h-inden-4-ol
1-(4-bromo-3,3-dimethylcyclohexyl)-3-methylbicyclo[3.1.0]hexan-3-ol
(3s)-5-[(1s,5s)-5-bromo-2,6,6-trimethylcyclohex-2-en-1-yl]-3-methylpent-1-en-3-ol
(2ar,3s,4ar,5s,7s,8r,8as)-3-bromo-2a,4a,5,8-tetramethyl-octahydrocyclobuta[d]inden-7-ol
(2r,3r,4s,5s,6r)-2-[(2r)-2-hydroxy-2-phenylethoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
(1s,2r,4ar,5r,8as)-5-bromo-2-isopropyl-4a,8-dimethyl-2,3,4,5,6,8a-hexahydro-1h-naphthalen-1-ol
(2s,3r,4s,5s,6r)-2-(4-hydroxy-3,5-dimethylphenoxy)-6-(hydroxymethyl)oxane-3,4,5-triol
2-(hydroxymethyl)-6-[2-(methoxymethyl)phenoxy]oxane-3,4,5-triol
1-o-β-d-glucopyranosyl-2-(3-hydroxyphenyl)-ethanol
{"Ingredient_id": "HBIN002848","Ingredient_name": "1-o-\u03b2-d-glucopyranosyl-2-(3-hydroxyphenyl)-ethanol","Alias": "NA","Ingredient_formula": "C14H20O7","Ingredient_Smile": "C1=CC(=CC(=C1)O)CCOC2C(C(C(C(O2)CO)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "8675","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
